Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.
- DOI
- 10.1080/14740338.2026.2719047
- Published
- 2026 Aug 14
- Container
- Expert opinion on drug safety
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14740338.2026.2719047,
title = {Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.},
author = {Vitale E and Cazzato G and Maistrello L and Della Mura M and Maiorano MFP and Ciccimarra F and Brunetti O and Calabrò C and Maiorano BA and Monteiro FSM and Erul E and Massari F and Rizzo A and Santoni M},
year = {2026},
journal = {Expert opinion on drug safety},
doi = {10.1080/14740338.2026.2719047},
url = {https://doi.org/10.1080/14740338.2026.2719047}
}RIS
TY - JOUR TI - Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis. AU - Vitale E AU - Cazzato G AU - Maistrello L AU - Della Mura M AU - Maiorano MFP AU - Ciccimarra F AU - Brunetti O AU - Calabrò C AU - Maiorano BA AU - Monteiro FSM AU - Erul E AU - Massari F AU - Rizzo A AU - Santoni M PY - 2026 JO - Expert opinion on drug safety DO - 10.1080/14740338.2026.2719047 UR - https://doi.org/10.1080/14740338.2026.2719047 ER -
APA
E, V., G, C., L, M., M, D. M., MFP, M., F, C., O, B., C, C., BA, M., FSM, M., E, E., F, M., A, R., & M, S. (2026). Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.. Expert opinion on drug safety. https://doi.org/10.1080/14740338.2026.2719047
Source records
- pubmed · retrieved 2026-09-25T21:49:21.701Z